Followers | 62 |
Posts | 9562 |
Boards Moderated | 0 |
Alias Born | 03/29/2015 |
Sunday, December 31, 2023 8:33:36 AM
After long enough, time becomes nearly as important as the quality of what is (eventually) delivered.
If I tell the 70+ year olds and 80+ year olds here that NWBO will hit $50 a share suddenly but not for another 5 years, then the time factor makes the quality of the outcome far less impactful. Even the 50+ year olds 60+ year olds are losing prime years to enjoy the money.
That said NWBO shareholders can, after each delay, just decide to keep lowering their expectations in terms of the eventual payout and how long it will take to get there. While they don’t get voted free shares like management they can ante up more and lower their dollar cost average a bit, though being overweight in NWBO that is not risk-free as time is a factor.
Patients, well, patients don’t have that luxury, not the ones who need L and not the ones who need Direct though by the time Durect ever hits the market most of the patients in dire need will sadly not be concerned at all.
Hopefully 2023 is the last year we ever have to have this discussion but that’s up to NWBO and what kind of relationship they’ve built with regulators. Hopefully their slowness and silence (beyond what the law requires) earned many brownie points with FDA and MHRA they will finally cash in.
Recent NWBO News
- Form NT 10-K - Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405 • Edgar (US Regulatory) • 03/01/2024 10:04:38 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/02/2023 01:31:35 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/16/2023 10:11:54 PM
- Epazz, Inc. (OTC Pink: EPAZ) ZenaDrone Demonstration to Defense Departments of UAE and Saudi Arabia • InvestorsHub NewsWire • 11/15/2023 12:19:31 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/09/2023 09:30:39 PM
- Epazz, Inc. (OTC Pink: EPAZ) US Navy Collaboration ZenaDrone 1000 • InvestorsHub NewsWire • 11/09/2023 01:00:34 PM
- Epazz, Inc. (OTC Pink: EPAZ) US Navy Collaboration ZenaDrone 1000 Extreme Weather Demo • InvestorsHub NewsWire • 11/07/2023 12:29:43 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/09/2023 08:36:14 PM
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM